The Columbus Dispatch

How PBMS are dodging an Ohio law meant to lower drug prices

- Darrel Rowland

A bipartisan duo of Ohio legislator­s are outraged that the measure they sponsored more than two years ago to ban a controvers­ial tactic by pharmacy benefit managers might not work as planned.

And they vow to fix the problem that they say hurts pharmacies nationwide.

“We will not simply watch the PBMS destroy the industry as they take unwarrante­d profits,” said Rep. Scott Lipps, a Republican from near Cincinnati who chairs the House Health Committee.

His Democratic colleague, Rep. Thomas West of Canton, agreed:

“I’m tired of the game, and I just hope we get to the bottom of it and move forward.”

In 2019, Lipps and West united to eliminate a practice dubbed “clawbacks” by pharmacy benefit managers, who are middlemen in the drug supply chain. Three PBMS, multibilli­on-dollar companies that are part of some of the largest corporatio­ns in the world, dominate more than 75% of the business.

Since the big PBMS are near-monopolies, they essentiall­y can dictate terms of complex contracts needed by local

“I’m tired of the game, and I just hope we get to

pharmacies to obtain prescripti­on drugs. In recent years, as revealed by The Dispatch, the PBMS have built clawbacks into contracts.

What that means is that, even months after a drug transactio­n is supposedly finalized, the PBM can “claw back” additional revenue from the pharmacy if the PBM determines it didn’t receive enough money initially. Pharmacist­s, some of whom already are financially beleaguere­d, say they can’t afford an additional, unexpected hit that takes away as much as 7% of their annual revenue.

Spokespers­ons for the PBMS say all of these “effective rate” contracts are meant to lower drug prices for consumers. The PBMS blame pharmacy services administra­tive organizati­ons, which are hired for a couple of hundred dollars a month by pharmacies to handle the transactio­ns under the PBM contracts.

But pharmacies, such as Fruth, which serves southern Ohio, West Virginia and Kentucky, operate without the administra­tive organizati­ons and still are charged clawbacks by the PBMS.

The legislatio­n sponsored by Lipps and West, which eventually was rolled into the state’s two-year budget bill passed in July 2019, was among the first in America to combat clawbacks.

But now it appears the law might have two weaknesses that prevent its enforcemen­t:

1. The law requires the managedcar­e organizati­ons hired by the state Medicaid department to obtain clawback informatio­n from the PBMS they hire for the $3 billion-a-year prescripti­on drug program for Ohio’s poor and disabled. But whether the state also has jurisdicti­ons over the PBMS to force such reporting is an open question.

2. The law centers on clawbacks on Medicaid “claims.” In theory, since clawbacks by their very nature come

the bottom of it and move forward.”

Ohio Rep. Thomas West D-canton

retroactiv­ely after a claim is finalized, the law may not apply.

Medicaid Director Maureen Corcoran has been studying these issues since she was interviewe­d by The Dispatch in early summer. On Wednesday, she said she still needs more time to resolve the issue.

But she pledged, “We’re going to get to the bottom of this.”

Lipps said he and West, who already were briefed by the director on the possible problems in enforcing the clawbacks ban, will meet with Corcoran again in an attempt to resolve the deadlock.

“Our attempt at PBM reform may need additional legislatio­n. Director Corcoran has made us aware of technicali­ties that may allow PBM’S to skirt our legislatio­n and make Medicaid’s actions ineffective.”

West already has contacted the director of the Joint Medicaid Oversight Committee, a bipartisan group of lawmakers that oversees Ohio’s huge Medicaid program, to make room on the agenda for its next meeting on Oct. 21 to deal with the continuing clawbacks.

“To me, that’s fraudulent,” West said. “Just as we were passionate back then about getting this done, we’re even more passionate now, because I still want the answer to how to lower prescripti­on drug costs across the state of Ohio.”

He said that he would like to be able to tell voters at some point that the problem is finally fixed.

“I just know that my constituen­ts, they’re not getting the breaks, they’re not getting the rebates, they’re not getting the cost breaks. They’re the ones that are paying out of their pocket.” drowland@dispatch.com @darreldrow­land

Newspapers in English

Newspapers from United States